Nisa Investment Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4K | Sell |
944
-112
| -11% | -$1.47K | ﹤0.01% | 2169 |
|
|
2025
Q1 | $23.2K | Buy |
1,056
+7
| +0.7% | +$154 | ﹤0.01% | 1820 |
|
|
2024
Q4 | $28K | Buy |
1,049
+67
| +7% | +$1.79K | ﹤0.01% | 1834 |
|
|
2024
Q3 | $26.2K | Buy |
982
+96
| +11% | +$2.56K | ﹤0.01% | 1820 |
|
|
2024
Q2 | $16K | Buy |
886
+632
| +249% | +$11.4K | ﹤0.01% | 2018 |
|
|
2024
Q1 | $4.63K | Buy |
254
+37
| +17% | +$675 | ﹤0.01% | 2129 |
|
|
2023
Q4 | $2.37K | Sell |
217
-1,310
| -86% | -$14.3K | ﹤0.01% | 2173 |
|
|
2023
Q3 | $8.75K | Buy |
1,527
+1,502
| +6,008% | +$8.61K | ﹤0.01% | 2200 |
|
|
2023
Q2 | $194 | Buy |
+25
| New | +$194 | ﹤0.01% | 2711 |
|
|
2023
Q1 | – | Sell |
-2,900
| Closed | -$26K | – | 2577 |
|
|
2022
Q4 | $26K | Sell |
2,900
-15,300
| -84% | -$137K | ﹤0.01% | 1976 |
|
|
2022
Q3 | $178K | Buy |
18,200
+15,300
| +528% | +$150K | ﹤0.01% | 1301 |
|
|
2022
Q2 | $23K | Buy |
+2,900
| New | +$23K | ﹤0.01% | 2010 |
|
|
2021
Q4 | – | Sell |
-10,257
| Closed | -$170 | – | 2270 |
|
|
2021
Q3 | $170 | Buy |
+10,257
| New | +$170 | ﹤0.01% | 1468 |
|